The effect of bevacizumab in the treatment of corneal neovascularization: new analysis method

Session Details

Session Title: Cornea Surgical II

Session Date/Time: Tuesday 16/09/2014 | 08:00-10:30

Paper Time: 09:58

Venue: Boulevard B

First Author: : J.Hwang SOUTH KOREA

Co Author(s): :    M. Park   M. Kim           

Abstract Details

Purpose:

To evaluate the short term effects of bevacizumab injections on the regression of corneal neovascularization and to introduce the new analysis method for corneal neovascularization

Setting:

Prospective/St. Mary's Hospital Seoul, Korea

Methods:

20 patients with corneal NV were injection with 0.05 mg of bevacizumab through subconjunctival. The patients were prospectively followed-up for one month and 3 months after the injections. Corneal NV areas, as shown on corneal slit-lamp photographs stored in JPEG format, were calculated using Image J software and use the color spectrum softeare before the injection, one week after the injection, and one month, 3 months after the injection. The two analysis methods were compared before and after the injections.

Results:

The mean decrease in corneal NV area one and three months after injection were not significant. And Color spectrum method showed higher reproducibility than Image J method

Conclusions:

The mean decrease in corneal NV area one and three months after injection were not significant. And Color spectrum method showed higher reproducibility than Image J method

Financial Interest:

NONE